The Potential of Autologous Platelet-Rich Plasma Gel for Diabetic Foot Ulcer Care Among Older Adults: A Systematic Review and Meta-Analysis
Hesti Platini,Keyzha Adammayanti,Sidik Maulana,Putu Moradha Kharisma Putri,Welly Layuk,Juan Alessandro Jeremis Maruli Nura Lele,Hartiah Haroen,Sri Hartati Pratiwi,Faizal Musthofa,Arpit Mago
DOI: https://doi.org/10.2147/tcrm.s433033
2024-01-26
Therapeutics and Clinical Risk Management
Abstract:Hesti Platini, 1 Keyzha Amartya Adammayanti, 2 Sidik Maulana, 3 Putu Moradha Kharisma Putri, 2 Welly Grivin Layuk, 2 Juan Alessandro Jeremis Maruli Nura Lele, 2 Hartiah Haroen, 4 Sri Hartati Pratiwi, 1 Faizal Musthofa, 5, 6 Arpit Mago 7 1 Department of Medical-Surgical Nursing, Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 2 Clinical Clerkship Program, Faculty of Medicine, Universitas Kristen Indonesia (UKI), UKI Hospital East Jakarta, Special Capital Region, Indonesia; 3 Master of Nursing Program, Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 4 Department of Community Health Nursing, Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 5 Nursing Internship Program, Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 6 West Sapphire Medical-Surgical Ward, Santosa Bandung Central, Bandung, West Java, Indonesia; 7 Department of Clinical Medicine, Jawaharlal Nehru Medical College, Belagavi, India Correspondence: Hesti Platini, Department of Medical-Surgical Nursing, Faculty of Nursing, Universitas Padjadjaran, Bandung, West Java, 40132, Indonesia, Tel +62 822-1671-8363, Email Introduction: Poorly controlled diabetes mellitus can lead to the development of diabetic foot ulcers (DFU), which is a frequent complication in patients. However, several diabetes management guidelines for older adults do not mention the occurrence of DFUs. Nowadays, Autologous Platelet-Rich Gel (APG) is being used for treating diabetic ulcers. APG is an innovative platelet-derived product with many advantages, such as being low-cost, easy to produce, and readily available materials. Additionally, it does not lead to any rejection reaction. Objective: This study aims to assess the safety and efficacy of APG as a novel treatment of DFU compared with standard treatment in older adult patients. Methods: Randomized Controlled Trials (RCTs) were searched using PubMed, Cochrane, Google Scholar, Wiley, and PlosOne. The keywords have been arranged using the Boolean operator, including autologous platelet-rich gel, DFU, and elderly. The data was screened by inclusion and exclusion criteria. The final inclusion study was analyzed and synthesized by tabulation, clusterization, contextual and thematic approach, and assessed for risk of bias using ROB 2.0. Meta-analysis was conducted by using Review Manager 5.4 and the Mantel Haenszel method. Results: Eight RCTs with 598 patients were eligible for the present analysis. Compared with standard care/conventional treatment, APG could significantly improve the healing wound in patients with diabetic foot ulcers (Relative risk (RR) 1.32, 95% confidence interval (CI) 1.22– 1.57, p < 0.0001), shortened the healing time (Mean difference [MD] − 16.97 days (95% CI: − 32.64 to − 1.29; p < 0.00001), shortened the length of hospital stay (MD= − 20.11, 95% CI: − 38.02, − 2.20; p = 0.03), and amputation rate (MD= 0.36, 95% CI: 0.16, 0.84; p = 0.02). Conclusion: APG treatment can better treat DFU in terms of duration of healing, wound healing, length of hospital stay, and amputation prevention than the standard treatment. Keywords: autologous platelet-rich plasma gel, diabetic foot ulcers, older adult The prevalence of Diabetes Mellitus increases significantly with age. 1,2 Most diagnosed cases lie between the fourth and seventh decades of life. 3 Recent statistics indicate that over 326 million working-age individuals are affected by DM, distinct from the 122.8 million individuals aged 65 years and above. 3 These figures are expected to increase to 438.2 million and 253.4 million in the coming decades. 3 One of the most frequent complications experienced by individuals with poorly managed DM is DFU. This condition often arises due to inadequate glycemic control, underlying neuropathy, peripheral vascular disease, or insufficient foot care. 4 Additional factors contributing to the risk of DFU include vision impairment, irregular gait patterns, decreased mobility, and other medical conditions. Furthermore, the likelihood of significant amputations rises as individuals grow older in conjunction with the greater occurrence of these contributing factors. Diabetic feet are rarely mentioned in some guidelines for diabetes management in older adults. 5,6 As people age, neuropathy, foot abnormalities, and peripheral arterial disease (PAD) increase, leading to an elevated risk of amputation, including those without diabetes. The management of foot ulcers neces -Abstract Truncated-
health care sciences & services